Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03742219
Other study ID # 17-X-88
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date June 5, 2017
Est. completion date March 1, 2020

Study information

Verified date March 2021
Source Ohio University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the change in disease prevalence over time in impoverished urban communities in Lima, Peru.


Description:

The aim is to track the changes in disease prevalence of people living in impoverished urban communities in Lima over the next 10 years. Based on data collected in prior years and in an ongoing manner, Ohio University Global Health teams will be introducing interventions focused to positively impact disease states and trends in this population. The current focus is on chronic lifestyle related diseases and their precursors: cardiovascular disease, hypertension, dyslipidemia, diabetes, and overweight / obesity.


Recruitment information / eligibility

Status Terminated
Enrollment 861
Est. completion date March 1, 2020
Est. primary completion date October 1, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 12 Years and older
Eligibility Inclusion Criteria: - minors age 12-17 presenting to the free community clinic, with a responsible adult who can give consent; minors will give assent. - consenting adults of any age who present to the clinic. Exclusion Criteria: - adults who are unable to give consent.

Study Design


Intervention

Behavioral:
Lifestyle Modification
Community awareness: a) individuals will be made aware of their own chronic lifestyle diseases and risk factors b) communities will be made aware of their aggregated data concerning chronic lifestyle related diseases and risk factors. Education for individuals and communities on the meaning of the lifestyle diseases and risk factors. a) individual and small group sessions explaining diseases and lifestyle measures that are helpful, b) community level education to tentatively include i) shopping guides and recipes, ii) urban gardening projects, iii) puppet shows and other community presentations, iv) literature and posters.

Locations

Country Name City State
United States Ohio University Athens Ohio

Sponsors (1)

Lead Sponsor Collaborator
Ohio University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Weight weight in kilograms will be utilized to determine body mass index yearly for 10 years
Primary Systolic blood pressure measured with a manual sphygmomanometer in millimeters of mercury yearly for 10 years
Primary Diastolic Blood Pressure measured with a manual sphygmomanometer in millimeters of mercury yearly for 10 years
Primary glycosylated hemoglobin measured in percent via fingerstick capillary blood and portable analyzer periodically over 10 years
Primary Total cholesterol measured in percent via fingerstick capillary blood and portable analyzer periodically over 10 years
Primary Low-density lipoprotein cholesterol measured in percent via fingerstick capillary blood and portable analyzer periodically over 10 years
Primary High density lipoprotein cholesterol measured in percent via fingerstick capillary blood and portable analyzer periodically over 10 years
Primary Triglycerides measured in percent via fingerstick capillary blood and portable analyzer periodically over 10 years
Secondary Herth Hope Index validated survey utilized to evaluate level of hope for the future yearly for 10 years
Secondary Household hunger scale validated survey to measure food insecurity yearly for 10 years
Secondary Patient Health Questionnaire - 4 (PHQ-4) used to evaluate depression and anxiety yearly for 10 years
Secondary Exercise vital sign the minutes of exercise during the last week yearly for 10 years
Secondary Perceived Stress Scale validated survey to evaluate level of stress yearly for 10 years
Secondary 24 hour dietary recall report of all foods consumed in the last 24 hours, which will be utilized to determine the nutritional value of dietary intake yearly for 10 years
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A